Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-17

FDA Approved: FESOTERODINE FUMARATE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's generic fesoterodine fumarate through an original ANDA for the treatment of overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

ORIG AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)